Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly EBT Margin of 21.82% in Q4 2025, down 67.29% quarter-over-quarter from 13.04% in Q3 2025, and up 396.0% on a YoY basis from 4.4% in Q4 2024.
Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' EBT Margin history runs 16 years deep, the most recent figure standing at 21.82% for Q4 2025.
- In Q4 2025, EBT Margin rose 396.0% year-over-year to 21.82%; the TTM figure through Dec 2025 stood at 19.47% (up 728.0% YoY), while the FY2025 annual figure was 20.35%, up 1916.0% from the prior year.
- EBT Margin was 21.82% for Q4 2025 at Sonoma Pharmaceuticals, down from 13.04% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2.54% in Q3 2021 to a low of 142.82% in Q1 2022.
- Historically, EBT Margin has averaged 40.4% across 5 years, with a median of 29.61% in 2023.
- The sharpest annual moves came in 2021 and 2023: EBT Margin plunged 5397 bps in 2021, then surged 9508 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 32.53% in 2021, then sank by 99 bps to 64.71% in 2022, then soared by 55 bps to 29.41% in 2023, then gained by 12 bps to 25.79% in 2024, then climbed by 15 bps to 21.82% in 2025.
- The last three EBT Margin figures came in at 21.82% (Q4 2025), 13.04% (Q3 2025), and 30.93% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -21.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.82% |
| Sep 30, 2025 | -13.04% |
| Jun 30, 2025 | -30.93% |
| Mar 31, 2025 | -14.06% |
| Dec 31, 2024 | -25.79% |
| Sep 30, 2024 | -12.94% |
| Jun 30, 2024 | -29.40% |
| Mar 31, 2024 | -39.52% |
| Dec 31, 2023 | -29.41% |
| Sep 30, 2023 | -47.53% |
| Jun 30, 2023 | -42.34% |
| Mar 31, 2023 | -47.74% |
| Dec 31, 2022 | -64.71% |
| Sep 30, 2022 | -27.53% |
| Jun 30, 2022 | -23.15% |
| Mar 31, 2022 | -142.82% |
| Dec 31, 2021 | -32.53% |
| Sep 30, 2021 | -2.54% |
| Jun 30, 2021 | -29.80% |
| Mar 31, 2021 | -130.37% |